Skip to content

The international, multicentre collaboration on portal vein obstruction revascularisation therapy after liver transplantation in paediatric: evaluation of standard of care

Portal vein Obstruction Revascularisation Therapy After Liver transplantation registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20671
Enrollment
400
Registered
2021-02-24
Start date
2021-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal vein obstruction

Interventions

No interventions
this is a retrospective, observational registry

Sponsors

University Medical Centre Groningen (UMCG)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Treated for PVO (PVAS or PVT) after liver transplantation (all interventions are included and conservative treatment as well) 2. Age at intervention <18 years 3. Intervention in period 01-01-2001 and 01-01-2021

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Primary and secondary patency after PVO intervention, and patient and graft survival after PVO intervention

Secondary

MeasureTime frame
Prevalence of PVO after liver transplantation, clinical and imaging characteristics of patients before treatment, technical success numbers of all treatment strategies, occurrence of complications after treatment and post-interventional management (especially anticoagulant/antiplatelet prophylaxis).

Contacts

Public ContactBader Alfares

University Medical Centre Groningen

b.a.m.alfares@umcg.nl+31 (0)50 361 4260

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)